In the subgroup analyses that were adjusted according to the clinicopathological characteristics including fibrosis severity, the serum ITIH4 expression in the HCC with NAFLD group was significantly higher than that in the NASH group (Table 3). This evidence concerns the gene ITIH4 and metabolic dysfunction-associated steatohepatitis.